Ask AI
ProCE Banner Activity

Exploring the Expanded Clinical Utility of HER2 IHC Scoring in Metastatic Breast Cancer

Video
  • Educate HCPs on the clinical significance of identifying patients with certain low levels of HER2 in metastatic breast cancer and raising awareness on the evolution of the HER2 spectrum
  • Highlight key considerations that impact HER2 IHC scoring and interpretation
  • Review guidance for pathologists to accurately report HER2 status

Released: August 20, 2025

Sponsored By

AstraZeneca

ProCE Banner